Effects of Sacubitril/Valsartan on Neprilysin Targets and The Metabolism of Natriuretic Peptides in Chronic Heart Failure: A Mechanistic Clinical StudyHélène Nougue, Damien Logeart, Théo Pezel et al.|European Journal of Heart Failure|2018Cited by 153
proANP Metabolism Provides New Insights Into Sacubitril/Valsartan Mode of ActionMichel Thibault, Nicolas Vodovar, Jérôme Cartailler et al.|Circulation Research|2022Cited by 8
Right Ventriculoarterial Coupling Surrogates and Long-Term Survival in LVAD Recipients: Results of the ASSIST-ICD Multicentric RegistryMaxime Beneyto, Clément Delmas, Paul Achouh et al.|Journal of Cardiac Failure|2024Cited by 8
Implantable cardiac defibrillator leads dysfunction after LVAD implantationVincent Galand, Raphaël P. Martins, Christophe Leclercq et al.|Pacing and Clinical Electrophysiology|2020Cited by 7
Deconvolution of BNP and NT-proBNP Immunoreactivities by Mass Spectrometry in Heart Failure and Sacubitril/Valsartan TreatmentHélène Nougue, Nicolas Vodovar, Michel Thibault et al.|Clinical Chemistry|2023Cited by 6